Dror Limon
Impact in
- Otorhinolaryngology top 5%
- Head and Neck Cancer Studies
- Genetics top 10%
- Glioma Diagnosis and Treatment
Papers in
- Genetics 10
- Glioma Diagnosis and Treatment 9
-
- Head and Neck Cancer Studies 7
- Co-authors
- Deborah T. Blumenthal (6 shared papers)Felix Bokstein (5 shared papers)Aron Popovtzer (7 shared papers)Yuval Nachalon (3 shared papers)Alexander Lossos (2 shared papers)Gideon Bachar (3 shared papers)Zvi Ram (4 shared papers)Jacob Shvero (3 shared papers)
- Journals
- Journal of Neuro-Oncology (8 papers)International Journal of Radiation Oncology*Biology*Physics (5 papers)Frontiers in Oncology (4 papers)Neuro-Oncology (2 papers)Neuro-Oncology Advances (2 papers)
- Partner nations
- IsraelUnited StatesItaly
In The Last Decade
Dror Limon
45 papers receiving 776 citations
Dror Limon's Hit Papers
Peers
Comparison fields: 5 of 55
- Otorhinolaryngology 125
- Genetics 180
- Pulmonary and Respiratory Medicine 291
- Oncology 229
- Cancer Research 61
Countries citing papers authored by Dror Limon
This map shows the geographic impact of Dror Limon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dror Limon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dror Limon more than expected).
Fields of papers citing papers by Dror Limon
This network shows the impact of papers produced by Dror Limon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dror Limon. The network helps show where Dror Limon may publish in the future.
Co-authors
The 25 scholars most cited alongside Dror Limon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial Hit paper breakdown → | 2024 | 134 |
| 2 | 2016 | 85 | |
| 3 | 2022 | 77 | |
| 4 | 2014 | 74 | |
| 5 | 2020 | 55 | |
| 6 | 2017 | 49 | |
| 7 | 2015 | 45 | |
| 8 | 2016 | 39 | |
| 9 | 2017 | 25 | |
| 10 | 2017 | 21 | |
| 11 | 2016 | 18 | |
| 12 | 2016 | 16 | |
| 13 | 2015 | 14 | |
| 14 | 2015 | 14 | |
| 15 | 2018 | 13 | |
| 16 | 2024 | 12 | |
| 17 | 2017 | 12 | |
| 18 | 2018 | 11 | |
| 19 | 2018 | 9 | |
| 20 | 2022 | 7 |
About Dror Limon
Dror Limon is a scholar working on Genetics, Otorhinolaryngology, Pulmonary and Respiratory Medicine, Oncology and Radiation, having authored 49 papers that have together received 788 indexed citations. Recurring topics across this work include Brain Metastases and Treatment (11 papers), Glioma Diagnosis and Treatment (9 papers), Head and Neck Cancer Studies (7 papers), Advanced Radiotherapy Techniques (4 papers), Lung Cancer Research Studies (3 papers), Pain Management and Opioid Use (3 papers), Meningioma and schwannoma management (3 papers) and Prostate Cancer Diagnosis and Treatment (3 papers). The work is most often cited by research in Otorhinolaryngology (125 citations), Genetics (180 citations), Pulmonary and Respiratory Medicine (291 citations), Oncology (229 citations) and Cancer Research (61 citations). Dror Limon has collaborated with scholars based in Israel, United States and Italy. Frequent co-authors include Deborah T. Blumenthal, Felix Bokstein, Aron Popovtzer, Yuval Nachalon, Alexander Lossos, Gideon Bachar, Zvi Ram, Jacob Shvero, Michal Yalon-Oren and Emanuela Cagnano. Their work appears in journals such as Journal of Neuro-Oncology, International Journal of Radiation Oncology*Biology*Physics, Frontiers in Oncology, Neuro-Oncology and Neuro-Oncology Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.